Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)

CNY 6.36

(0.47%)

Market Cap (In CNY)

7.94 Billion

Revenue (In CNY)

1.79 Billion

Net Income (In CNY)

181.86 Million

Avg. Volume

11.95 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.2-7.18
PE
-
EPS
-
Beta Value
0.112
ISIN
CNE100001070
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Ke Wang
Employee Count
-
Website
https://www.qhsh.com.cn
Ipo Date
2011-02-18
Details
Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.